TNF and metabolic dysfunction-associated steatotic liver disease: Consumption of resveratrol for 12 weeks showed significant effectiveness, and decreased insulin-resistant ALT, AST, low-density lipoprotein cholesterol (LDLC), TC, and TNF-α were found in a NAFLD patient, but further confirmation and investigation of adverse effects, further efficacy and safety demonstration were required [216].